Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Sartoretto, Adrian
NCT06360679: Clinical Feasibility Study of the BariTon™ System in Obese or Overweight Patients.	Recruiting	N/A	10	RoW	Endoscopic gastric restriction and biliodigestive diversion	BariaTek Medical	Obesity	10/24	06/25
REGENT-1, NCT04725890: Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes	Active, not recruiting	N/A	60	RoW	The DyaMX Device, Duodenal Mucosal Regeneration	Endogenex, Inc.	Type 2 Diabetes	03/24	09/24
NCT05587491: HybridAPC for Gastric Mucosal Ablation in Obese Patients.	Recruiting	N/A	15	RoW	Hybrid Argonplasma coagulation (HAPC)	Erbe Elektromedizin GmbH, ERBE AUSTRALIA PTY LTD	Obesity, Adiposity	02/25	03/25
Manolios, Antonia
REGENT-1, NCT04725890: Safety and Feasibility of a Novel Endoscopic Intervention for the Treatment of Type II Diabetes	Active, not recruiting	N/A	60	RoW	The DyaMX Device, Duodenal Mucosal Regeneration	Endogenex, Inc.	Type 2 Diabetes	03/24	09/24